S R Evans

Summary

Affiliation: The George Washington University
Country: USA

Publications

  1. ncbi Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer
    S R Evans
    Department of Surgery, George Washington University Medical Center, Washington, DC 20037, USA
    Clin Cancer Res 4:1591-5. 1998
  2. ncbi Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft
    S R Evans
    Department of Surgery, George Washington University Medical Center, Washington, DC 20037, USA
    Clin Cancer Res 4:2869-76. 1998
  3. ncbi A stepwise approach to laparoscopic Nissen fundoplication: avoiding technical pitfalls
    S R Evans
    Department of Surgery, The George Washington University Medical Center, Washington, DC 20037, USA
    Arch Surg 135:723-8. 2000
  4. ncbi The modern medical school graduate and general surgical training: are they compatible?
    Stephen Evans
    Department of Surgery, George Washington University Medical Center, 2150 Pennsylvania Ave NW, Washington, DC 20037, USA
    Arch Surg 137:274-7. 2002
  5. ncbi The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor
    M Shabahang
    Department of Surgery, Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC, USA
    Ann Surg Oncol 3:144-9. 1996
  6. ncbi Palliative superselective intra-arterial chemotherapy for advanced nonresectable gastric cancer
    I B Shchepotin
    Department of Surgery, George Washington University, Washington, DC 20037, USA
    J Gastrointest Surg 3:426-31. 1999
  7. ncbi Predictors of outcome in 100 consecutive laparoscopic antireflux procedures
    P G Jackson
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Am J Surg 181:231-5. 2001

Collaborators

  • Babak Sarani
  • P G Jackson
  • I B Shchepotin
  • M Shabahang
  • R Askari
  • M A Gleiber
  • J Hanfelt
  • V Chorny
  • R J Nauta
  • A E Buffan
  • J M Nolla
  • R V Brenner
  • R R Buras
  • L M Schumaker

Detail Information

Publications7

  1. ncbi Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer
    S R Evans
    Department of Surgery, George Washington University Medical Center, Washington, DC 20037, USA
    Clin Cancer Res 4:1591-5. 1998
    ....
  2. ncbi Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft
    S R Evans
    Department of Surgery, George Washington University Medical Center, Washington, DC 20037, USA
    Clin Cancer Res 4:2869-76. 1998
    ..The mechanism for this impressive growth inhibition is not yet elucidated and warrants further investigation...
  3. ncbi A stepwise approach to laparoscopic Nissen fundoplication: avoiding technical pitfalls
    S R Evans
    Department of Surgery, The George Washington University Medical Center, Washington, DC 20037, USA
    Arch Surg 135:723-8. 2000
    ..We believe that this approach will not only reduce complications by highlighting potential problems at each stage but also make it easier to teach others...
  4. ncbi The modern medical school graduate and general surgical training: are they compatible?
    Stephen Evans
    Department of Surgery, George Washington University Medical Center, 2150 Pennsylvania Ave NW, Washington, DC 20037, USA
    Arch Surg 137:274-7. 2002
  5. ncbi The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor
    M Shabahang
    Department of Surgery, Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC, USA
    Ann Surg Oncol 3:144-9. 1996
    ..Present modes of therapy are associated with high rates of recurrence. 1, 25-Dihydroxyvitamin D3, the active metabolite of vitamin D, serves as a potent antiproliferative agent in human cancer cells...
  6. ncbi Palliative superselective intra-arterial chemotherapy for advanced nonresectable gastric cancer
    I B Shchepotin
    Department of Surgery, George Washington University, Washington, DC 20037, USA
    J Gastrointest Surg 3:426-31. 1999
    ..The results confirmed that superselective intra-arterial chemotherapy conferred a highly significant survival advantage compared to control or systemic intravenous chemotherapy adjusted for all patient characteristics (P <0.0001)...
  7. ncbi Predictors of outcome in 100 consecutive laparoscopic antireflux procedures
    P G Jackson
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Am J Surg 181:231-5. 2001
    ..The optimal surgical candidate is a patient under the age of 50 whose typical symptoms completely resolve with acid suppression therapy...